Lucie brings her diverse experiences in medicine, science, venture capital and technology to bear in leading Rimidi Diabetes, a software company focused on improving the cycle of care in diabetes management. After earning a BA in Physics from Middlebury College, Lucie joined the National Security Agency followed by Raytheon Systems Corporation as a Signal Communications Analyst. She then joined Monarch Capital Partners, a venture capital firm focused on emerging wireless and satellite communications technologies. With a desire to shift her scientific focus to human health, Lucie completed the Medical Scientist Training Program at Emory University, earning a joint M.D. and a Ph.D. in pharmacology. Following internship at UPMC Magee Womens’ Hospital in Pittsburgh, Lucie saw an opportunity to make an impact on our healthcare system that was undergoing massive changed fueled by economic pressures, policy change, and technological innovations. She co-founded Rimidi Diabetes in 2012.
Updates from IPaT